NYSE: CATX
Perspective Therapeutics, Inc.CIK 0000728387 · Pharmaceutical Preparations
8-K
Filed May 27, 2026
· Period ending May 27, 2026
Perspective Therapeutics holds routine annual meeting, elects six directors for one-year terms
3 material changes detected. Sign up free to read the summary.
8-K
Filed May 22, 2026
· Period ending May 21, 2026
Perspective Therapeutics to present interim clinical trial results at ASCO 2026
2 material changes detected. Sign up free to read the summary.
Partner
Trade CATX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 11, 2026
· Period ending May 11, 2026
Summary not yet generated.
10-Q
Filed May 11, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed May 4, 2026
· Period ending May 4, 2026
Summary not yet generated.
8-K
Filed Apr 20, 2026
· Period ending Apr 18, 2026
Summary not yet generated.
10-K
Filed Mar 16, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 10, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Mar 26, 2025
· Period ending Dec 31, 2024
Summary not yet generated.